| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 540 |
| 1 | METHOTREXATE SODIUM | 539 |
| 2 | INFLIXIMAB | 530 |
| 3 | TOCILIZUMAB | 525 |
| 4 | ETANERCEPT | 513 |
| 5 | RITUXIMAB | 507 |
| 6 | SULFASALAZINE | 507 |
| 7 | ABATACEPT | 504 |
| 8 | METHOTREXATE | 497 |
| 9 | LEFLUNOMIDE | 496 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 143 | 0.0246 |
| 1 | GOLIMUMAB | 288 | 0.0229 |
| 2 | PRAMIPEXOLE DIHYDROCHLORIDE | 68 | 0.0140 |
| 3 | FEBUXOSTAT TABLETS 40 MG | 125 | 0.0120 |
| 4 | DIMENHYDRINATE | 128 | 0.0119 |
| 5 | FEBUXOSTAT | 145 | 0.0085 |
| 6 | SULFASALAZINE | 507 | 0.0068 |
| 7 | COLCHICINE | 139 | 0.0052 |
| 8 | TOFACITINIB CITRATE | 65 | 0.0048 |
| 9 | ALENDRONATE SODIUM | 484 | 0.0048 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 549 |
| 1 | Corticosteroid [EPC] | 537 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 525 |
| 3 | Aminosalicylate [EPC] | 508 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 507 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 504 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 497 |
| 7 | Antirheumatic Agent [EPC] | 496 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 301 |
| 9 | Vitamin B12 [EPC] | 245 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 139 | 0.0052 |
| 1 | Aminosalicylate [EPC] | 508 | 0.0050 |
| 2 | Antirheumatic Agent [EPC] | 496 | 0.0047 |
| 3 | Provitamin D2 Compound [EPC] | 130 | 0.0044 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 525 | 0.0038 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 504 | 0.0036 |
| 6 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 7 | Parenteral Iron Replacement [EPC] | 39 | 0.0028 |
| 8 | Interleukin-17A Antagonist [EPC] | 104 | 0.0028 |
| 9 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 32 | 0.0020 |